Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$64.37+0.20 (+0.31%)
Close on Nov 13, 2026Market cap $3.15BP/E –Yield –
Celcuity operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Celcuity's operating cash flow for the twelve months ending Sep 30, 2026 was -$213.12M. For fiscal 2025 it was -$153.28M. The highest annual figure on record is -$2.89M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$153.28M | – |
| FY2024 | Dec 31, 2024 | -$83.47M | – |
| FY2023 | Dec 31, 2023 | -$53.81M | – |
| FY2022 | Dec 31, 2022 | -$36.01M | – |
| FY2021 | Dec 31, 2021 | -$20.31M | – |
| FY2020 | Dec 31, 2020 | -$7.15M | – |
| FY2019 | Dec 31, 2019 | -$6.00M | – |
| FY2018 | Dec 31, 2018 | -$6.08M | – |
| FY2017 | Dec 31, 2017 | -$4.95M | – |
| FY2016 | Dec 31, 2016 | -$2.89M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$66.23M | – |
| Q2 FY2026 | Jun 30, 2026 | -$55.43M | – |
| Q1 FY2026 | Mar 31, 2026 | -$55.07M | – |
| Q4 FY2025 | Dec 31, 2025 | -$36.40M | – |
| Q3 FY2025 | Sep 30, 2025 | -$44.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$36.21M | – |
| Q1 FY2025 | Mar 31, 2025 | -$35.85M | – |
| Q4 FY2024 | Dec 31, 2024 | -$27.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.56M | – |
| Q2 FY2024 | Jun 30, 2024 | -$18.07M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.07M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.54M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.75M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.66M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.87M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.48M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.31M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.29M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.12M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.05M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.52M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.11M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.56M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.83M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.70M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.48M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.23M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.59M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.52M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.77M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.45M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.11M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.63M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.26M | – |
| Q1 FY2017 | Mar 31, 2017 | -$947.14K | – |
| Q4 FY2016 | Dec 31, 2016 | -$704.01K | – |
See a number that looks wrong?